2012-10-05 16:16:21 - Recently published research from Global Markets Direct, "Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Graft Versus Host Disease (GVHD). Graft Versus Host Disease (GVHD) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468353_graft_versus_host_disease_gvhd_pipeli ..


Note*: Certain sections in

the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Graft Versus Host Disease (GVHD).
* A review of the Graft Versus Host Disease (GVHD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Graft Versus Host Disease (GVHD) pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Graft Versus Host Disease (GVHD).
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Graft Versus Host Disease (GVHD) pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Graft Versus Host Disease (GVHD) Overview
Therapeutics Development
An Overview of Pipeline Products for Graft Versus Host Disease (GVHD)
Graft Versus Host Disease (GVHD) Therapeutics under Development by Companies
Graft Versus Host Disease (GVHD) Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Graft Versus Host Disease (GVHD) Therapeutics - Products under Development by Companies
Graft Versus Host Disease (GVHD) Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Graft Versus Host Disease (GVHD) Therapeutics Development
Osiris Therapeutics, Inc.
Athersys, Inc.
Rigel Pharmaceuticals, Inc.
IMMUNOMEDICS, INC
Accentia Biopharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc.
Soligenix, Inc.
NeoStem, Inc.
Cytomedix, Inc.
JCR Pharmaceuticals Co., Ltd.
MediPost Co., Ltd.
Alder Biopharmaceuticals Inc.
Lumen Therapeutics
Adeona Pharmaceuticals, Inc.
Kiadis Pharma B.V.
CBio Limited
Bellicum Pharmaceuticals, Inc.
REGiMMUNE Corporation
ADIENNE Pharma & Biotech
Dr. Falk Pharma GmbH
Lycera Corp.
Sigmoid Pharma.
Graft Versus Host Disease (GVHD) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
MultiStem - Drug Profile
remestemcel-L - Drug Profile
milatuzumab - Drug Profile
ATIR - Drug Profile
Rhitol - Drug Profile
beclomethasone dipropionate - Drug Profile
clazakizumab - Drug Profile
JR-031 - Drug Profile
cyclophosphamide - Drug Profile
Anti-CD4 802-2 - Drug Profile
Promostem - Drug Profile
inolimomab - Drug Profile
LT-1951 - Drug Profile
Mycophenolate + Corticosteroids - Drug Profile
imatinib mesylate - Drug Profile
Velcade + Tacrolimus + Methotrexate + Blood Stem Cell Transplantation - Drug Profile
sirolimus - Drug Profile
Prograf + Rapamune + Velcade - Drug Profile
Pentostatin + Tacrolimus + Methotrexate - Drug Profile
Maraviroc + Allogeneic Stem Cell Transplantation - Drug Profile
XToll - Drug Profile
aldesleukin - Drug Profile
aldesleukin - Drug Profile
Busulfan + Fludarabine + Cytoxan + Bone Marrow Transplantation - Drug Profile
Allogenic Mesenchymal Stem Cells + Prednisone + Cyclosporine - Drug Profile
Tacrolimus + Sirolimus - Drug Profile
Dexamethasone + Tacrolimus - Drug Profile
rituximab - Drug Profile
bortezomib - Drug Profile
sirolimus - Drug Profile
Tacrolimus + Mycophenolate Mofetil + Sirolimus - Drug Profile
etanercept - Drug Profile
Prograf + Methotrexate - Drug Profile
budesonide - Drug Profile
Therapeutic allogeneic lymphocytes program - Drug Profile
Natural Killer Cells - Drug Profile
etanercept - Drug Profile
Allogeneic Mesenchymal Stem Cells - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468353&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.